A., Matar, C., Farnworth, E., & Perdign, G
Results: nejm.org/doi/full/10.10 #ADA2023 Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released phase 2 trial results demonstrating 25% weight loss in half of people with #obesity
What You Get $9.90 Instant Download Get The Plan Instant Download $9.90 Who This Is For This is for you if: Youre on GLP-1 and cooking feels impossible right now Nausea or fatigue means standing at the stove isnt happening You still want to hit protein without cooking anything You need something you can eat in 35 bites with zero prep You want a week structured around grocery foods, not recipes Not A Fit If You want a full cooking-based meal plan You want strict macros or aggressive calorie targets Youre looking for medical treatment advice FAQ Is this an Ozempic / Wegovy / Mounjaro / Zepbound meal plan PDF
Chen, J.-J
Ongoing Innovation: Companies should continue to innovate and seek new indications and formulations (such as combination therapies) to broaden the scope of GLP-1 receptor agonists
A glutathione powder is also available
